🔎 Trials Near Me

홈 › 버킷 림프종 › 버지니아

버지니아의 버킷 림프종 임상 시험

버킷 림프종 관련 연구 7개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • University of Virginia Cancer Center, Charlottesville
  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • 외 2개
피험자 모집 중2상
366 Days – 46 Years · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중3상
18세 ~ 39세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • University of Virginia Cancer Center, Charlottesville
  • Children's Hospital of The King's Daughters, Norfolk
  • VCU Massey Comprehensive Cancer Center, Richmond
  • 외 1개
피험자 모집 중2상
365 Days · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중2상
1세 ~ 30세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • University of Virginia Cancer Center, Charlottesville
  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • 외 3개
피험자 모집 중3상
365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  • Research Site, Richmond
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06137118

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.